Lataa...

Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at three years

BACKGROUND: Alzheimer’s disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. PARTICIPANTS: Nineteen MC...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Päätekijät:	Pardo, José V., Lee, Joel T., Kuskowski, Michael A., Munch, Kristin R., Carlis, John V., Sheikh, Sohail A., Surerus, Christa, Lewis, Scott M., McCarten, J. Riley, Fink, Howard, McPherson, Susan, Shah, Hemant H., Rottunda, Susan, Dysken, Maurice W.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	2010
Aiheet:	Article
Linkit:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2918397/ https://ncbi.nlm.nih.gov/pubmed/20447873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2009.09.005
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at three years

Samankaltaisia teoksia